BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7494555)

  • 1. Ventricular remodeling: insights from pharmacologic interventions with angiotensin-converting enzyme inhibitors.
    Goldstein S; Sharov VG; Cook JM; Sabbah HN
    Mol Cell Biochem; 1995 Jun 7-21; 147(1-2):51-5. PubMed ID: 7494555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
    Sabbah HN; Shimoyama H; Kono T; Gupta RC; Sharov VG; Scicli G; Levine TB; Goldstein S
    Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
    Jugdutt BI; Idikio H; Uwiera RR
    Mol Cell Biochem; 2007 Sep; 303(1-2):27-38. PubMed ID: 17426929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
    Jugdutt BI; Lucas A; Khan MI
    Can J Cardiol; 1997 Jul; 13(7):657-68. PubMed ID: 9251578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
    Konstam MA; Rousseau MF; Kronenberg MW; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1992 Aug; 86(2):431-8. PubMed ID: 1638712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An angiotensin-converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major.
    Karvounis HI; Zaglavara TA; Parharidis GE; Nouskas IG; Hassapopoulou EP; Gemitzis KD; Louridas GE
    Am Heart J; 2001 Feb; 141(2):281. PubMed ID: 11174351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
    Schieffer B; Wirger A; Meybrunn M; Seitz S; Holtz J; Riede UN; Drexler H
    Circulation; 1994 May; 89(5):2273-82. PubMed ID: 8181153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
    Konstam MA; Kronenberg MW; Rousseau MF; Udelson JE; Melin J; Stewart D; Dolan N; Edens TR; Ahn S; Kinan D
    Circulation; 1993 Nov; 88(5 Pt 1):2277-83. PubMed ID: 8222122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular remodeling and angiotensin-converting enzyme inhibitors.
    Goldstein S; Sabbah H
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S27-31. PubMed ID: 7700061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
    Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
    J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy. Effects on left ventricular and myocyte structure and function.
    Spinale FG; Holzgrefe HH; Mukherjee R; Hird RB; Walker JD; Arnim-Barker A; Powell JR; Koster WH
    Circulation; 1995 Aug; 92(3):562-78. PubMed ID: 7634471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
    J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction.
    González GE; Wilensky L; Cassaglia P; Morales C; Gelpi RJ
    Cardiovasc Pathol; 2016; 25(3):208-213. PubMed ID: 26897484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
    Rastogi S; Sharov VG; Mishra S; Gupta RC; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
    Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
    Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study.
    Hoffmann U; Globits S; Stefenelli T; Loewe C; Kostner K; Frank H
    J Magn Reson Imaging; 2001 Jul; 14(1):16-22. PubMed ID: 11436209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nisoldipine and/or enalapril on left ventricular function and exercise capacity in patients with recent anterior myocardial infarction and mild cardiac dysfunction.
    Romano M; Cardei S; de Arcangelis E; Monteforte I; Capaldo M; Muto P; Marchegiano R; Kilama MO; Condorelli M
    Am Heart J; 1997 Mar; 133(3):268-72. PubMed ID: 9060793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.